title: [Urapidil: hypotension induced in neuroanesthesia].
abstract: The authors report their experience on the use of urapidil in 31 patients, submitted to neurosurgical procedures. Urapidil, administered both in the inductive (0.7-1 mg/kg) and in preoperative phases (0.6-0.8 mg/kg/h), produced a MAP decrease of about 25% without significant variations in cardiac frequency or of other monitored parameters.
authors.affiliation: Istituto di Anestesia e Rianimazione, Università degli Studi di Napoli.
authors.forename: M
authors.initials: M
authors.lastname: Scafuro
authors.forename: G
authors.initials: G
authors.lastname: Cafaggi
authors.forename: F
authors.initials: F
authors.lastname: Petrella
authors.forename: A M
authors.initials: AM
authors.lastname: Di Gregorio
authors.forename: G
authors.initials: G
authors.lastname: Ciotola
authors.forename: A
authors.initials: A
authors.lastname: Moraci
authors.forename: E
authors.initials: E
authors.lastname: Niele
authors.forename: M
authors.initials: M
authors.lastname: Chiefari
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000601:surgery*; D005260:Female; D006801:Humans; D007022:Hypotension / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010879:Piperazines
chemical_list: D010879:Piperazines; C015568:urapidil
vernacular_title: Urapidil: ipotensione indotta in neuroanestesia.